Global Vitality, Inc. dba Enzyme Process International

Warning LetterOpen

United StatesFEI 3002757933Issued Apr 16, 2020

View FDA's record for FEI 3002757933

Source: FDA warning letter records. FDA has not published the text of this letter. To check it, open FDA's record for this establishment, listed under FEI 3002757933.

Violations0

Issue DateApr 16, 2020

Product TypeDrugs

StatusOpen

Letter Details

Firm: Global Vitality, Inc. dba Enzyme Process International
Location: United States
FEI Number: 3002757933
Country: United States
Issue Date: April 16, 2020
Issuing Office: N/A
Product Type: Drugs
Status: Open

Summary

Global Vitality, Inc., operating as Enzyme Process International, received an FDA Warning Letter on April 16, 2020, regarding drug products. Based on the limited metadata available, the specific violations cannot be detailed as no subject line information was provided with this record. The warning falls under FDA drug regulation authority, though the issuing office is not specified in the available metadata. A review of the complete letter would be necessary to identify the particular compliance issues cited.

Global Vitality, Inc. dba Enzyme Process International FDA Warning Letter, April 16, 2020